Similarly, ATAD-2 mediates MKK3/6 inhibition preventing p38MAPK activation, and ATAD-2 targeting resulted into p53 mediated apoptosis in hepatocellular carcinoma [67]. This evidence concerns the gene ATAD2 and hepatocellular carcinoma.